Kancera Future Growth
Future criteria checks 5/6
Kancera is forecast to grow earnings and revenue by 77.1% and 87.7% per annum respectively while EPS is expected to grow by 160.8% per annum.
Key information
77.1%
Earnings growth rate
160.8%
EPS growth rate
Biotechs earnings growth | 46.7% |
Revenue growth rate | 87.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 26 Aug 2024 |
Recent future growth updates
Recent updates
Companies Like Kancera (STO:KAN) Are In A Position To Invest In Growth
Aug 13We Think Kancera (STO:KAN) Needs To Drive Business Growth Carefully
Dec 06Is Kancera (STO:KAN) In A Good Position To Deliver On Growth Plans?
Jul 19Companies Like Kancera (STO:KAN) Are In A Position To Invest In Growth
Mar 08We Think Kancera (STO:KAN) Can Afford To Drive Business Growth
Jun 29We're Hopeful That Kancera (STO:KAN) Will Use Its Cash Wisely
Mar 08Here's Why We're Watching Kancera's (STO:KAN) Cash Burn Situation
Aug 02We're Not Very Worried About Kancera's (STO:KAN) Cash Burn Rate
Apr 06Here's Why We're Not Too Worried About Kancera's (STO:KAN) Cash Burn Situation
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -15 | N/A | N/A | 1 |
12/31/2025 | 202 | 169 | N/A | 169 | 2 |
12/31/2024 | N/A | -52 | N/A | -52 | 2 |
6/30/2024 | N/A | -53 | -51 | -51 | N/A |
3/31/2024 | N/A | -60 | -51 | -51 | N/A |
12/31/2023 | N/A | -65 | -56 | -56 | N/A |
9/30/2023 | N/A | -60 | -52 | -52 | N/A |
6/30/2023 | N/A | -61 | -58 | -58 | N/A |
3/31/2023 | N/A | -58 | -57 | -57 | N/A |
12/31/2022 | N/A | -52 | -48 | -48 | N/A |
9/30/2022 | N/A | -51 | -53 | -53 | N/A |
6/30/2022 | N/A | -52 | -50 | -50 | N/A |
3/31/2022 | N/A | -49 | -44 | -44 | N/A |
12/31/2021 | N/A | -46 | -44 | -44 | N/A |
9/30/2021 | N/A | -45 | -41 | -41 | N/A |
6/30/2021 | 0 | -44 | -39 | -39 | N/A |
3/31/2021 | 0 | -38 | -39 | -39 | N/A |
12/31/2020 | 0 | -40 | -39 | -39 | N/A |
9/30/2020 | 0 | -35 | -29 | -29 | N/A |
6/30/2020 | 0 | -34 | -29 | -29 | N/A |
3/31/2020 | 0 | -40 | -36 | -36 | N/A |
12/31/2019 | 3 | -36 | -33 | -33 | N/A |
9/30/2019 | 4 | -41 | -46 | -46 | N/A |
6/30/2019 | 3 | -44 | -53 | -53 | N/A |
3/31/2019 | 3 | -41 | -41 | -41 | N/A |
12/31/2018 | 0 | -46 | -45 | -45 | N/A |
9/30/2018 | 0 | -46 | -50 | -50 | N/A |
6/30/2018 | 0 | -52 | -41 | -41 | N/A |
3/31/2018 | 0 | -59 | N/A | -54 | N/A |
12/31/2017 | 0 | -56 | N/A | -54 | N/A |
9/30/2017 | 0 | -51 | N/A | -41 | N/A |
6/30/2017 | 0 | -39 | N/A | -40 | N/A |
3/31/2017 | 0 | -27 | N/A | -26 | N/A |
12/31/2016 | 0 | -22 | N/A | -23 | N/A |
9/30/2016 | 0 | -22 | N/A | -22 | N/A |
6/30/2016 | 0 | -20 | N/A | -19 | N/A |
3/31/2016 | 0 | -20 | N/A | -22 | N/A |
12/31/2015 | 0 | -20 | N/A | -21 | N/A |
9/30/2015 | 0 | -19 | N/A | -24 | N/A |
6/30/2015 | 0 | -18 | N/A | -23 | N/A |
3/31/2015 | 0 | -17 | N/A | -21 | N/A |
12/31/2014 | 0 | -16 | N/A | -19 | N/A |
9/30/2014 | 2 | -13 | N/A | -9 | N/A |
6/30/2014 | 2 | -13 | N/A | -9 | N/A |
3/31/2014 | 2 | -12 | N/A | -8 | N/A |
12/31/2013 | 2 | -7 | N/A | -7 | N/A |
9/30/2013 | 2 | -16 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KAN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
Earnings vs Market: KAN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: KAN is expected to become profitable in the next 3 years.
Revenue vs Market: KAN's revenue (87.7% per year) is forecast to grow faster than the Swedish market (0.9% per year).
High Growth Revenue: KAN's revenue (87.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KAN's Return on Equity is forecast to be high in 3 years time